Arun BS , Sandeep J Bijapur , Arun BS , Manjunath C Nanjappa , Tejeswar Reddy P , Rockey Katheria ,
Sandeep J Bijapur, Arun BS, Manjunath C Nanjappa et al. Gamma-Glutary Transferase: A Novel Biomarker For Predicting Coronary Artery Disease. J Cardiovasc Med Surg. 2020;6(1):29-32.
Background: Gamma Glutamy l Transferase (GGT) is involved in pathogenesis of various cardiovascular diseases. Aim: To assess serum GGT level in predicting significant CAD (Coronary Artery Disease).
Methods: 200 patients undergoing CAG were studied. Serum GGT level was compared between normal/insignificant CAD Group (Group 1) and significant CAD Group (Group 2). Comparison between various subgroups was done.
Results: Mean age of study population was 57.63 ± 10.78 years. Mean of serum GGT level in Group 1 was 31.61 ± 20.17 and in Group 2 was 39.48 ± 22.91. (p = 0.004). Mean ± SD of SVD, DVD and TVD were 43.29 ± 24.05, 36.8 ± 20.47 and 39.06 ± 26.04 and were not statistically significant.
Conclusion: Serum GGT level can be used as a noninvasive biomarker to predict significant CAD.
No records found.
Sandeep J Bijapur, Arun BS, Manjunath C Nanjappa et al. Gamma-Glutary Transferase: A Novel Biomarker For Predicting Coronary Artery Disease. J Cardiovasc Med Surg. 2020;6(1):29-32.
| Received | Accepted | Published |
|---|---|---|
| N/A | N/A | N/A |
Monday 22 June 2026, 10:49:39 (IST)
Download citation
Highlight selected keywords in the article text.
| Received | N/A |
| Accepted | N/A |
| Published | N/A |